Frederick W Driscoll's Net Worth

$2.32 Million

Estimate Recalculated Mar 26, 2024 06:05PM EST

Who is Frederick W Driscoll?

Frederick W Driscoll has an estimated net worth of $2.32 Million. This is based on reported shares across multiple companies, which include Flexion Therapeutics Inc, NOVAVAX INC, NantKwest, Inc., OXIGENE INC, Cue Biopharma, Inc., Conformis Inc, MEI Pharma, Inc., Cellectar Biosciences, Inc., Renovacor, Inc., Invivyd, Inc., GENELABS TECHNOLOGIES INC /CA, and Abpro Corp.

SEC CIK

Frederick W Driscoll's CIK is 0001129890

Past Insider Trading and Trends

2016 was Frederick W Driscoll's most active year for acquiring shares with 8 total transactions. Frederick W Driscoll's most active month to acquire stocks was the month of May. 2017 was Frederick W Driscoll's most active year for disposing of shares, totalling 5 transactions. Frederick W Driscoll's most active month to dispose stocks was the month of January. 2011 saw Frederick W Driscoll paying a total of $398,600.00 for 170,000 shares, this is the most they've acquired in one year. In 2017 Frederick W Driscoll cashed out on 69,434 shares for a total of $736,679.04, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Flexion Therapeutics Inc No price found

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-30.68K
$8.50
-$260,780.00
0
Nov 19
Form 4
+1,044.78%
28K
—
—
30.68K
Jun 1
Form 3
—
0
—
—
0
Form 4
—
0
$15.45
-$45,341.70
7.78K
Scheduled
Mar 23
Form 4
-30.63%
-3.43K
$13.93
-$431,096.04
7.78K
Scheduled
Feb 28
Form 4
+12.07%
1.13K
$9.01
$10,217.34
10.53K
Dec 20
Form 4
—
0
—
—
0
Dec 20
Form 4
+11.42%
963
$8.92
$8,589.96
9.4K
May 20
Form 4
+42.13%
2.5K
$9.87
$24,668.00
8.43K
May 17
Form 4
+72.80%
2.5K
$9.19
$22,971.75
5.93K
May 16
Form 4
—
0
—
—
0
Jan 4
Form 4
+90.85%
1.31K
$11.91
$15,614.01
2.75K
May 20
Form 4
—
0
—
—
0
Jan 21
Form 4
∞
1.44K
$11.91
$17,186.13
1.44K
Nov 20
Form 4
—
0
—
—
0
Mar 3
Form 3
—
0
—
—
0
No matching records found

NOVAVAX INC (NVAX) Snapshot price: $3.7829

VP, CFO & Treasurer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 2
Form 4
—
0
—
—
0
Mar 1
Form 4
∞
20K
$1.18
$23,600.00
20K
Aug 9
Form 4
—
0
—
—
0
Mar 10
Form 4
—
0
—
—
0
Apr 15
Form 4
—
0
—
—
0
Mar 15
Form 4
∞
10K
—
—
10K
Aug 24
Form 3
—
0
—
—
0
No matching records found

NantKwest, Inc. (IBRX) Snapshot price: $4.185

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-37.41%
-65.30K
$10.23
-$668,051.57
109.23K
Aug 11
Form 4
—
0
—
—
0
Jun 10
Form 4
+113.00%
92.59K
—
—
174.53K
Jun 6
Form 4
+50.02%
27.32K
—
—
81.94K
Jun 7
Form 4
∞
54.62K
—
—
54.62K
Sep 18
Form 3
—
0
—
—
0
No matching records found

OXIGENE INC (OTLC) Snapshot price: $0.03975

President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
May 28
Form 4
—
0
—
—
0
Jul 2
Form 3
—
0
—
—
0
Form 4
—
0
—
—
0
Jan 2
Form 4/A
+190.48%
80K
—
—
122K
Oct 3
Form 4
+190.48%
80K
—
—
122K
Jul 15
Form 4
—
0
—
—
0
Jul 28
Form 4/A
+5.26%
2K
$7.31
$14,620.00
40K
May 20
Form 4
+5.26%
2K
$7.31
$14,620.00
40K
May 20
No matching records found

Cue Biopharma, Inc. (CUE) Snapshot price: $2.39

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Jan 4
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Jun 26
Form 3
—
0
—
—
0
No matching records found